Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medline Industries
MedTech
Medline hit with FDA warning letter over defective heart syringes
After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns being leveled by the FDA.
Ben Adams
Apr 8, 2026 1:11pm
Medline makes Nasdaq debut, raising $6.26B in year's largest IPO
Dec 17, 2025 11:11am
Medline sets terms for massive $5.37B Nasdaq IPO
Dec 9, 2025 11:19am
FDA amplifies neurosurgery kit recall at Medline, Integra
Jul 22, 2025 12:30pm
FDA elevates Medline recall of endotracheal ventilator tubes
Jun 13, 2024 1:08pm
Medline sews up Ecolab's surgical drape business for $950M
May 2, 2024 12:26pm
